Quince Therapeutics, Inc.

Quince Therapeutics, Inc.

QNCX · Nasdaq

Quince Therapeutics, Inc. (QNCX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Quince Therapeutics, Inc. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 90 days

EPS estimate

-9.95

Revenue estimate

0

Past earnings

14 Aug 2026
EPS actual
-12.31 (+56.1%)
estimate -28.02
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
76.88 (+395.7%)
estimate -26.00
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Apr 2026
EPS actual
-0.18 (+2.6%)
estimate -0.18
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Nov 2025
EPS actual
-0.25 (-16.3%)
estimate -0.22
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Quince Therapeutics beat consensus estimates in its latest earnings, with EPS of -$12.31 versus an estimate of -$28.02 and revenue meeting expectations at $0. In the prior quarter, EPS also came in ahead of estimates while revenue likewise met expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Dirk Thye
Employees
36
IPO date
09 May 2019
ISIN
US22053A1079
Website
quincetx.com

Frequently asked questions

When does Quince Therapeutics, Inc. (QNCX) next report earnings?

Quince Therapeutics, Inc. (QNCX) is scheduled to report earnings on November 18, 2026.

What was Quince Therapeutics, Inc.'s most recent earnings date?

Quince Therapeutics, Inc. (QNCX) last reported earnings on August 14, 2026.

Where is Quince Therapeutics, Inc. stock listed?

Quince Therapeutics, Inc. (QNCX) is listed on Nasdaq.